Spiden Company
Spiden is a medical technology company that develops optical and AI-based technology to analyze body fluids non-destructively and in real-time. Their goal is to achieve continuous, non-invasive, and medical-grade multi-biomarker monitoring through a next-generation wearable device, starting with glucose monitoring. Spiden's products aim to optimize treatment and increase safety for critical and high-risk patients. They were founded in 2019 and have received a grant in 2022.
.png)
Founded Date:
2017
Total Funding:
25250000
Investors Number:
8
Employee Number:
11-50
Number Of Exists:
11-50
Last Funding Type:
Seed
Industry:
Aging Biomarkers
Headquarters:
Freienbach, Schwyz, Switzerland
Funding Status:
Seed
Last Funding Date:
2021-04-29